AbCellera Biologics Inc (ABCL) is higher by Wednesday morning, with the stock rising 1.99% in pre-market trading to 20. ABCL's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 1% of stocks. AbCellera Biologics Inc has risen 11.55% over the past month, closing at $16.93 on September 1. During this period of time, the stock fell as low as $16.93 and as high as $22.63. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $45.25.
ABCL has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ABCL!